Sullivan will present the findings from the study, "Duodenal mucosal resurfacing prevents weight regain after tirzepatide withdrawal: REMAIN-1 multicenter, randomized, double-blind, sham-controlled clinical trial -- midpoint cohort results," abstract 642, at 8:30 a.m
Review of the published blood work shows low hemoglobin levels, slightly high liver enzymes, low Vitamin D, elevated clotting factors (D-dimer/fibrinogen), and elevated inflammatory markers (ESR)
Off-label use for weight management requires provider evaluation
Follow your clinician's guidance on any insulin dose adjustments
The UK SmPC specifically recommends monitoring INR when initiating semaglutide in patients taking warfarin or other coumarin derivatives